Quick Takeaways
- Atul Pande has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $2,452,106.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Atul Pande
- Location
- New York, NY
- Summary
- The estimated net worth of Atul Pande is at least $2,452,106 dollars as of 03 Apr 2025. Atul Pande is the Director of Immunovant, Inc. and owns shares of Immunovant, Inc. (IMVT) stock worth about $2.45M.
- Signature
- /s/ Eva Renee Barnett, attorney-in-fact for Atul Pande
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Atul Pande and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Immunovant, Inc. ($2,452,106).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Atul Pande
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| IMVT | Immunovant, Inc. | Director | $2,452,106 | 01 Apr 2025 | ||
| KRTX | Karuna Therapeutics, Inc. | Director | $0 | 18 Mar 2024 |
Insider Transactions Reported by Atul Pande:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.